GSK logo

GSK SG&A Expenses

Latest reported£9.20B GBP
GSK TTM SG&A Expenses · GBP (£0.00 → £9.20B)
High-resolution chart · PNG

GSK sg&a expenses history

Trailing twelve months (TTM) · GBP. Each value covers four complete reported quarters.

GSK plc American Depositary Shares (Each representing two Ordinary Shares) SG&A Expenses — Trailing twelve months (TTM) (GBP)
Period endingSG&A Expenses (GBP)
9,199,000,000
9,137,000,000
9,088,000,000
9,112,000,000
10,673,000,000
10,998,000,000
11,015,000,000
11,030,000,000
9,526,000,000
9,329,000,000
9,385,000,000
9,145,000,000
8,905,000,000
8,703,000,000
8,372,000,000
9,194,000,000
8,817,000,000
8,440,000,000
9,055,000,000
8,957,000,000
9,947,000,000
10,967,000,000
11,456,000,000
11,737,000,000
11,960,000,000
11,841,000,000
11,402,000,000
10,579,000,000
10,214,000,000
10,081,000,000
9,915,000,000
9,828,000,000
9,609,000,000
9,531,000,000
9,672,000,000
9,850,000,000
9,834,000,000
9,629,000,000
9,366,000,000
9,153,000,000
8,829,000,000
9,196,000,000
9,232,000,000
8,941,000,000
8,986,000,000
8,500,000,000
8,246,000,000
8,239,000,000
8,210,000,000
8,371,000,000
8,480,000,000
8,478,000,000
8,730,000,000
8,714,000,000
8,776,000,000
8,804,000,000
8,581,000,000
8,626,000,000
8,564,000,000
10,799,000,000
10,826,000,000
12,783,000,000
13,053,000,000
11,546,000,000
11,652,000,000
9,742,000,000
9,592,000,000
8,934,000,000
8,607,000,000
8,111,000,000
7,656,000,000
7,052,511,000
6,850,005,670
6,895,005,670
6,823,005,670
7,062,462,410
7,062,967,740
7,105,815,320
7,253,766,420
7,360,026,680
7,627,026,680
7,421,807,100
7,245,856,000
7,109,278,320
6,873,923,100
6,978,295,100
7,058,295,100
7,144,844,780
7,448,200,000
7,501,221,220
7,571,200,000
5,583,000,000
5,544,000,000
5,764,978,780
5,857,000,000
7,037,295,500
7,253,295,500
7,261,295,500
7,467,295,500
6,287,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.